Pulmonary Embolism
Conditions
Keywords
pulmonary embolism, pro-BNP, home treatment
Brief summary
The aim of this study is to investigate the safety of treatment of pulmonary embolism in an outpatient setting based on normal pro-BNP levels. The mortality rate and the incidence of hemodynamic instability as well as major bleeding and recurrent venous thromboembolism (VTE) in the outpatient group will be studied.
Detailed description
Pulmonary embolism is a major health problem. Because of risk for early hemodynamic instability and mortality, all patients with a recently diagnosed pulmonary embolism are treated in hospital. The clinical course of most patients is without complications. In practice most of the patients are only waiting in hospital in a good, clinical stable condition until their INR range is stable. This prospective management study is to investigate the safety of treatment of pulmonary embolism in an outpatient setting based on normal pro-BNP levels (\< 500 pg/ml). The incidence of complications due to the pulmonary embolism or its treatment will be followed during the first ten days of treatment.
Interventions
PROCEDUREhome treatment
Sponsors
Diakonessenhuis, Utrecht
Groene Hart Ziekenhuis
Reinier de Graaf Groep
St. Antonius Hospital
Study design
Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* outpatient with a pulmonary embolism, confirmed by locally approved guidelines * aged 18 years and above * written informed consent
Exclusion criteria
* hemodynamic or respiratory instability defined as one of the following; hypotension RR systolic\< 90 mmHg,pulse rate\> 100 bpm, need for oxygen therapy to maintain oxygen saturation above 90 %, collapse * illness unrelated to PE for which the patient would require hospitalization * pain requiring intravenous narcotics * thrombolysis * active bleeding or thrombopathy * pregnancy * in hospital patients * physical or psychiatric inability for home treatment * no support system at home renal insufficiency
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mortality rate due to pulmonary embolism or its treatment during a period of ten days in the outpatient group | — |
Secondary
| Measure | Time frame |
|---|---|
| Rate of re-admission due to pulmonary embolism or its treatment in the outpatient group: hemodynamic instability, major bleeding, recurrence of venous thromboembolism | — |
Countries
Netherlands
Outcome results
None listed